LGM Pharma Earns ISO 9001:2008 Re-certification

LGM Pharma Earns ISO 9001:2008 Re-certification

LGM Pharma Earns ISO 9001:2008 Re-certificationNASHVILLE, Tennessee – LGM Pharma, a leading supplier of active pharmaceutical ingredients (APIs) to various global pharmaceutical firms, headquartered in Nashville, Tennessee with administrative offices in Boca Raton, Florida, recently attained ISO 9001:2008 re-certification. This demonstrates continued success providing quality active pharmaceutical ingredients in an ethical and quality manner.

The benchmarks of the International Organization for Standardization (ISO) certify the ability of a company to provide standards for its employees, which are fair, virtuous and innovative. The ISO designation represents the only standard against which organizations can be certified.

As a leading supplier in the APIs industry, LGM Pharma continues to be a dynamic resource for the industry of global pharmaceutical research and development. The team at LGM Pharma specializes in full sourcing options as well as a vast range of both new and rare APIs for the R&D community. Clients can be assured of quality products gleaned from a reputable supply chain. The designation of ISO 9001:2008 certification assures clients that LGM Pharma not only complies with international standards of safety but also provides efficacious APIs with reliability and continual client support throughout the research and development process.

About LGM Pharma
LGM Pharma is a leading supplier of active pharmaceutical ingredients (APIs) to contract manufacturers and various global pharmaceutical firms involved in the manufacturing, research and development of a wide range of therapeutic chemical entities. In its commitment to improving health opportunities all over the world, LGM Pharma has forged partnerships with some of the biggest names in the pharmaceutical industry. Currently, the company supplies over 2,500 active pharmaceutical ingredients to its global clients.

  • Share:

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service